Gini Fleming to Leiomyosarcoma
This is a "connection" page, showing publications Gini Fleming has written about Leiomyosarcoma.
Connection Strength
0.388
-
Gemcitabine/docetaxel--welcome to a new standard. Gynecol Oncol. 2008 Jun; 109(3):313-5.
Score: 0.294
-
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia. Gynecol Oncol. 2012 Apr; 125(1):136-40.
Score: 0.094